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Abstract 
I r o n   d e f i c i e n c y   a n e m i a   ( I D A )   i s   a   f r e q u e n t   d i s o r d e r .   A l s o ,   i t   m a y   b e   a   s i g n   o f   u n d e r l y i n g   s e rious 
d i s e a s e s .   I r o n   d e f i c i e n c y   p o i n t s   t o   a n   o c c u l t   o r   f r a n k   b l e e d i n g   l e s i o n   w h e n   o c c u r r e d   i n   m e n   o r  
p o s t m e n o p a u s a l   w o m e n .   I n   t h i s   s t u d y ,   w e   a i m e d   t o   e v a l u a t e   t h e   d i a g n o s t i c   y i e l d   o f   e n d o s c o p y  
i n   p a t i e n t s   w i t h   I D A   a n d   t o   d e f i n e   p r e d i c t i v e   f a c t o r s   o f   g a s t r o intestinal (GI) lesions causing 
IDA. Ninety-one patients (77 women, 14 men; mean age: 43 years) who were decided to have 
esophago-duodenoscopy and/or colonoscopy for iron deficiency anemia were interviewed 
a n d   r e s p o n d e d   t o   a   q u e s t i o n n a i r e   t h a t   i n c l u d e d   c l i nical and biochemical variables. The en-
doscopic findings were recorded as GI lesions causing IDA or not causing IDA. Endoscopy 
r e v e a l e d   a   s o u r c e   o f   I D A   i n   1 8 . 6   %   o f   c a s e s .   T h e   r i s k   f a c t o r s   f o r   f i n d i n g   G I   l e s i o n s   c a u s i n g   I D A  
were as follows: male gender (p= 0.004), advanced age (> 50 years) (p= 0.010), weight loss 
(over 20% of total body weight lost in last 6 month) (p= 0.020), chronic diarrhea (p= 0.006), 
change of bowel habits (p= 0.043), epigastric tenderness (p= 0.037), raised carcinoembryonic 
antigen (CEA) level (normal range: 0-7 ng/mL) (p= 0.039), < 10 gr/dl hemoglobin (Hb) level 
(p=0.054). None of these risk factors had been present in 21 (23%) women younger than 51 
years. In this group, no patient had any GI lesion likely to cause IDA (negative predictive 
value= 100%). In multivariate analysis, advanced age (p=0.017), male gender (p< 0.01) and 
weight lost (p=0.012) found that associated with GI lesions in all patients. It may be an ap-
propriate clinical approach to consider these risk factors when deciding for gastrointestinal 
endoscopic evaluation in iron deficiency anemia. 
Key words: Iron deficiency anemia, gastrointestinal lesions, predictive risk factors, endoscopic in-
vestigation. 
Introduction 
Iron deficiency anemia (IDA) remains the most 
common cause of anemia and affects about 5–12% of 
non-pregnant  women  and  1–5 %   o f   m e n   h a v e   I D A  
[1-2]. I t   i s   a   r e s u l t   o f   b l o o d   l o s s   f r o m   t h e   g a s t r o i n t e s-
t i n a l   t r a c t   o r   t h e   u t e r u s   a n d   i s   a   r e q u i r i n g   f u r t h e r   i n-
vestigation due to sign of serious underlying disease. 
While menstrual blood loss is the commonest cause of 
I D A   i n   p r e -menopausal women, blood loss from the 
gastrointestinal (GI) tract is the commonest cause in 
adult men and post-menopausal women [3-6]. 
Laboratory  tests  used  to  make  the  diagnosis 
have not changed in many decades, their interpreta-
t i o n   h a s ,   a n d   t h i s   i s   p o s s i b l y   d u e   t o   t h e   a v a i l a b i l i t y   o f  
extensive testing in key populations. A   l o s s   o f   1 0   m l   o f  
blood per day is usually required for a positive based 
f e c a l   o c c u l t   b l o o d   t e s t   ( F O B T ) ,   a l t h o u g h   F O B T   p o s i-
tivity is highly dependent on the locus of the bleeding 
source. Bleeding lesions in the GI tract are identified 
in about 50% of patients with IDA [7-8]. Laboratory 
findings in IDA include elevated total iron-binding Int. J. Med. Sci. 2011, 8 
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capacity (TIBC), low transferrin saturation, and low 
serum iron level [9]. Those with a mixed diagnosis (an 
addition vitamin B12, folic acid deficiency or chronic 
disease  anemia),  the use  of  transferrin saturation in 
t h e   d i a g n o s i s   o f   I D A   h a v e   b e e n   d i s c o u r a g e d   [ 9 ] .  
When the diagnosis remains ambiguous after labora-
tory  results  are  analyzed,  a  bone  marrow  biopsy 
s h o u l d   b e   c o n s i d e r e d   i n   o r d e r   t o   m a k e   a   d e f i n i t i v e  
diagnosis. The absence of stainable iron is the “gold 
s t a n d a r d ” ,   f o r   d i a g n o s i s   o f   I D A .   Marrow examination 
shows, in addition to the absence of hemosiderin iron, 
a decrease in the proportion of sideroblasts, because 
too little iron is available to support siderotic granule 
formation.  
L o w e r   a n d   u p p e r   G I   t r a c t   e v a l u a t i o n   i s   r e c o m-
m e n d e d   t o   d i a g n o s e   t h e   c a u s e   o f   I D A ,   p a r t i c u l a r l y   i n  
men >50 and in post-menopausal women, in whom 
IDA i s   s u s p e c t e d   t o   o c c u r   f r o m   a   b l e e d i n g   l e s i o n .   G I  
evaluation  can  be  endoscopic  and  radiographic. 
Asymptomatic  colonic  and  gastric  carcinoma  may 
p r e s e n t   w i t h   I D A   a n d   e x c l u s i o n   o f   t h e s e   c o n d i t i o n s   i s  
of  prime  concern.  The upper endoscopic evaluation 
should include random gastric antral and fundic bi-
opsies in addition to duodenal biopsies in order to 
assess  the  histological  changes  of  atrophic  gastritis 
and  celiac  disease  [10].  U p p e r   G I   e n d o s c o p y   c a n   b e  
expected to reveal a cause in between 30 and 50% of 
patients. Small bowel biopsies should be taken during 
t h i s   e n d o s c o p y   a s   2 –3%  of  patients  presenting  with 
I D A   h a v e   c o e l i a c   d i s e a s e   [ 3 -6 ,   1 1 ] .   I r o n   d e f i c i e n c y  
anemia is considered as an alarm sign for the presence 
of possible GI malignancies, and inadequate evalua-
t i o n   o f   p a t i e n t s   w i t h   I D A   m a y   d e l a y   t h e   d i a g n o s i s   o f  
GI tumors especially colorectal cancer [12].  
I n   t h i s   s t u d y ,   w e   a i m e d   t o   e v a l u a t e   t h e   d i a g n o s-
t i c   y i e l d   o f   e n d o s c o p y   i n   p a t i e n t s   w i t h   I D A   a n d   t o  
define  predictive  factors  of  gastrointestinal  (GI)  le-
sions causing IDA and identify clinical and biochem-
i c a l   v a r i a b l e s   t h a t   p r e d i c t   t h e   o u t c o m e   o f   u p-
p e r / l o w e r   e n d o s c o p y   i n   o u t p a t i e n t s   w i t h   i r o n   d e f i-
c i e n c y   a n e m i a .   T h e   a i m   o f   o u r   s t u d y   w a s   t o   i n v e s t i-
gate  the  incidence  of  GI  pathological  findings  in 
symptomatic  and  asymptomatic  patients  with  IDA 
and to identify the predictive factors for such lesions.  
Patients and Methods 
From March 2006 to July 2007, 91 patients who 
visited  our  hematology  or  gastroenterology 
out-p a t i e n t   c l i n i c s   w i t h   a   d i a g n o s i s   o f   I D A   w e r e   c o n-
secutively enrolled into the present study after patient 
consent was obtained. Our study is prospective. 
The criteria for enrollment were as follows: 
1. Hemoglobin concentration ≤13 g/dl for men 
and ≤12 g/dl for women. 
2. Age > 18 years. 
3.  With  at least one of the following laboratory 
v a l u e s   c o n s i s t e n t   w i t h   i r o n   d e f i c i e n c y :   a   s e r u m   i r o n  
concentration <   1 0   µ g / m l   with a transferrin saturation 
≤ 20 percent, mean corpuscular volume (MCV) < 80 fL 
and a serum ferritin concentration ≤ 30 ng/ml. 
4. No  other  associated  disease  that  could  con-
tribute to anemia other than iron deficiency. 
All  patients  were  interrogated  and  examined 
according to Form-1 in Figure 1. This form developed 
b y   u s   f o r   t h i s   s t u d y .   T h e   p r e s e n c e   o f   d y s p e p t i c   c o m-
plaint and its severity calculated by presence of ab-
dominal pain, abdominal pain with hungry and an-
xiety, abdominal distension, nausea, vomiting, poor 
a p p e t i t e   a n d   s y m p t o m s   o f   g a s t r o e s o p h a g e a l   r e f l u x .  
All patients were graded 1 to 5 for these symptoms. 
Dyspepsia  score  of  patients were minimally 12 and 
maximally  60.  The  patients  investigated  previous 
smoking  history,  coronary  artery  disease,  diabetes 
mellitus and malignancy history in their family.  
Statistical Analysis 
 Data files were analyzed initially with Access 
and  SPSS  (version  13.0).  Chi-square  (x2)  tests  were 
performed to determine whether the clinical and bi-
ochemical variables were associated with a GI lesion. 
A   m u l t i v a r i a t e   a n a l y s i s   w a s   a p p l i e d   t o   i d e n t i f y   v a-
r i a b l e s   s i g n i f i c a n t l y   r e l a t e d   w i t h   t h e   o u t c o m e   o f   t h e   G I  
lesions. Multiple analyses were performed with Cox 
regression analysis. P < 0.05 was considered signifi-
cant in statistical analysis. 
Results 
Ninety-one  patients  fulfilled  the  entry  criteria 
a n d   w e r e   e n r o l l e d .   T h e i r   m e a n   a g e   w a s   4 3 . 3   ( 1 9 -81) 
years. 71 were patient a g e d   u n d e r   5 0   a n d   2 0   w e r e   o v e r  
50 years. 77 were female and 14 were male. Sixty-six 
of  women  were  pre-menopausal  and  11  were 
post-menopausal.  Presence  or  absence  of  GI  symp-
toms was evaluated in every patient. Table 1 describes 
the frequency predictive signs for possible gastroin-
testinal lesions in iron deficiency anemia patients. 
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Figure 1. Form-1 used in patients. 
 
Table 1. Frequency predictive signs for possible gastrointestinal lesions in iron deficiency anemia patients.  
  Yes (%)  No (%) 
Hematemesis  0 (0)  91 (100) 
Melena  4 (4.4)  87 (95.6) 
Hematochezia  8 ( 8.8)  83 (91.2) 
Hematuria  2 ( 2.2)  89 (97.8) 
Menorrhagia  20 (30.7)  46 (69.7) 
Diarrhea  3 (3.3)  88 (96.7) 
Constipation  39 (42.9)  52 (57.1) 
Change of bowel habits   5 (5.5)  86 (94.5) 
Lost weight  4 (4.4)  87 (95.6) Int. J. Med. Sci. 2011, 8 
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Frequently of NSAID1 use  3 (14.3)  88 (96.7) 
Intestinal parasite infection  7 (7.7)  84 (92.3) 
Previous IDA2 history  45 (49.5)  46 (50.5) 
Smoking  23 (25.3)  68 (74.7) 
Cancer in first degree relatives  22 (24.2)  69 (75.8) 
Cancer in family  28 (30.7)  63 ( 69.3)  
1Nonsteroidal anti-inflammatory drugs, 2Iron deficiency anemia 
 
Clinically, significant predictive signs for possi-
ble gastrointestinal lesions were demonstrated in 11 
patients. 8 patients had hematochezia and 4 had me-
l e n a .   O n l y   2   p a t i e n t s   h a d   h e m a t u r i a ,   3 9   h a d   c o n s t i p a-
t i o n ,   3   h a d   d i a r r h e a .   4 5   p a t i e n t s   h a d   b e e n   f o u n d   t o   b e  
iron  deficiency  anemia  previously.  20/66 
pre-menopausal women h a d   h e a v y   m e n s t r u a l   b l e e d-
ing. 28/91 patients had cancer in their family. At ad-
mission, significant physical examination findings of 
91 patients; 2 had hepatomegaly, 1 had splenomegaly 
and 8 had epigastric sensitivity (Table 2). 
1 8   o f   8 9   p a t i e n t s   h a d   f e c a l   o c c u l t   b l o o d   t e s t   p o s i-
tive,  6  patients   h a d   p a r a s i t e   i n   f e c e s ,   7   h a d   m i c r o-
scopic hematuria and 3 had positive sprue serological 
(antiendomysium  antibodies  IgA  and  tissue  trans-
glutaminase antibodies). 55 patients had no additional 
systemic disease, 13 patients had thyroid diseases (8 
had hypothyroidism, 5 had hyperthyroidism), 9 pa-
tients had diabetes mellitus (7 had diabetes mellitus 
type 2, 2 had diabetes mellitus type 1), 8 patients had 
h y p e r t e n s i o n ,   3   h a d   c o r o n a r y   a r t e r y   d i s e a s e ,   2   h a d  
c o l l a g e n   t i s s u e   d i s e a s e ,   2   h a d   i m m u n e   t h r o m b o c y t o-
penic purpura, 2 had hypophysial adenoma and 1 had 
Parkinson disease (Table 4). Table 5 shows biochemi-
c a l   c h a r a c t e r i s t i c s   o f   p a t i e n t s .   T h e i r   m e a n   h e m o g l o b i n  
level  was  10.2  g/dl  (range  6.4–12.7),  mean  white 
b l o o d   c e l l   c o u n t   w a s   7 0 9 5   l / m m 3 (range 3100-16900), 
mean platelet count was 326x103/mm3 (range 74-669), 
mean ferritin level was 7.5 ng/ml (range 1.38-28).  
Table 2. Significant physical examination findings in iron 
deficiency anemia patients 
  Yes (%)   No (%)  
Hepatosplenomegaly  3 (3.3)  88 (96.7) 
Abdominal mass  0 (0)  91 (100) 
Epigastric sensitivity  8 (8.8)  83 (91.2)  
  
Table 3. Laboratory findings related to iron deficiency in 
IDA patients. 
  Positive 
(Positive / totally, %)  
Negative (%) 
Fecal Occult Blood  16 (16/89, 18)  73 (82)  
Parasite in feces  6 (6/81, 7.4)  75 (92.6) 
Microscopic hema-
turia  
7 (7/91, 7.6)  84 (93.4) 
Lungs film  2 (2/88, 2.2)  86 (97.8) 
Sprue serological  3 (3/82, 3.6)  79 (96.4) 
Table 4. The additional systemic disease in IDA patients 
  Patients 
number 
 % 
Absent   55   60.4 
Thyroid diseases   13   14.2 
Diabetes Mellitus    9   9.8 
Hypertension   8   8.8 
Coronary artery disease   3   3.2 
Collagen tissue disease    2   2.1 
Immune thrombocyto-
penic purpura  
 2   2.1 
Hypophysial adenoma   2   2.1 
Parkinson disease   1   2.1 
 
Table 5. Biochemical variables of patients with iron defi-
ciency anemia 
  Patients 
Number 
Mean   Range  Normal lab. 
range 
Hb1 (gr/dl)  91  10.2  6.4–12.7  12-14/women 
14-15/men 
WBC2 
(l/mm3) 
91  7095  3100–16900  4.8-10.8 
Plt3 
(x103/mm3) 
91  326  74–669   150-400 
Ferritin 
(ng/ml) 
91  7.5  1.38–28  10-291/women 
22-322/men 
CRP4 
(gr/dl) 
83  0.66  0.1–7.6  0-5 
ESR5 
(mm/h) 
80  17.2  2–75  0-20 
CEA6 
(ng/ml) 
77  3.4  0.25–97  0-7 
1Hemoglobin, 2White blood cell, 3Platelets, 4C reactive protein, 
5Erythrocyte sedimentation rate, 6Carcinoembryonic antigen  
 
 
86  patients  underwent  upper  gastrointestinal 
tract  endoscopies  and  62  patients  underwent  upper 
a n d   l o w e r   g a s t r o i n t e s t i n a l   t r a c t   e n d o s c o p i e s .   A n  up-
p e r   G I   f i n d i n g ,   m a i n l y   a n t r a l   g a s t r i t i s   w a s   t h e   m o s t  
common  pathologic  finding  (n=23,  26.7  %).  The  ab-
normalities  considered  as  possible  causes  of  upper 
gastrointestinal lesions were Helicobacter pylori (HP) 
gastritis  (n=18),  duodenitis  (n=12),  pangastritis 
(n=11), c o e l i a c   d i s e a s e   ( n = 3 ) ,   g a s t r i c   u l c e r   ( n = 2 ) ,   d u-
odenal ulcer (n=2), erosive gastritis (n=1) and gastric 
tumor  (n=1).  The  lower gastrointestinal  tract  lesions 
r e g a r d e d   a s   p o s s i b l e   c a u s e s   o f   I D A   i n c l u d e d   h e-
morrhoid (n=19), chronic colitis (n=2), inflammatory Int. J. Med. Sci. 2011, 8 
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intestinal disease (n=2), interstitial colitis (n=1) and 
colorectal cancer (n=1) (Table 6). 
 
Table 6. Pathological conditions of the GI tract in iron 
deficiency anemia patients 
Diagnosis  Frequency  Result/Number of 
process, (%) 
Non-diagnostic  12  12/86, (13.9) 
Antral gastritis  23  23/86, (26.7) 
Hemorrhoid  19  19/66, (28.7) 
H.1 pylori gastritis  18  18/86, (20.9) 
Duodenitis  12  12/86, (13.9) 
Pangastritis  11  11/86, (12.7) 
Anal fissure  5  5/66, (7.5) 
Colonic polyp  4  4/66, (6.0) 
Diverticulitis  3  3/66, (4.5)  
Coeliac disease  3  3/86, (3.4) 
Gastric ulcer  2  2/86, (2.3) 
Duodenal ulcer  2  2/86, (2.3) 
Chronic colitis  2  2/66, (3.0) 
IID2  2  2/66, (3.0) 
Atrophic gastritis  2  2/86, (2.3) 
Interstitial colitis  1  1/86, (1.1) 
Gastric polyp  1  1/86, (1.1) 
Erosive gastritis  1  1/86, (1.1) 
Gastric cancer  1  1/86, (1.1) 
Colonic cancer  1  1/66, (1.5) 
1Helicobacter, 2Inflammatory intestinal disease 
  
 
A   l i s t   o f   t h e   u p p e r   a n d   l o w e r   G I   p a t h o l o g i c a l  
conditions associated with IDA is included in Table 7. 
The  patients  were  interviewed  and  responded  to  a 
questionnaire that included clinical and biochemical 
v a r i a b l e s .   T a b l e   8   i s   s h o w n   t h a t   r a t e   o f   c l i n i c a l l y   s i g-
nificant lesions in IDA with positively symptoms-sign 
or laboratory results. The presence of advanced age 
( > 5 0   y e a r s ) ,   m a l e   g e n d e r ,   d i a r r h e a ,   l o s t   w e i g h t ,  
c h a n g e   o f   b o w e l   h a b i t s ,   e p i g a s t r i c   t e n d e r n e s s ,   p o s i-
tively serological sprue, hemoglobin levels less than 
1 0   g / d l   a n d   h i g h   C E A   l e v e l   ( > 5   p g / m l )   w e r e   a s s o-
ciated with an increased likelihood of significant ga-
strointestinal  lesions  (p<0.05);  melena,  constipation, 
c a n c e r   i n   f i r s t   d e g r e e   r e l a t i v e s ,   f e c a l   o c c u l t   t e s t   p o s i-
tivity, high C-reactive protein (CRP) and erythrocyte 
sedimentation rate (ESR) level were associated with 
limited positively findings (p≤ 0.19). 
T h e   r i s k   f a c t o r s   f o r   f i n d i n g   G I   l e s i o n s   c a u s i n g  
I D A   w e r e   a s   f o l l o w s :   m a l e   g e n d e r   ( p =   0 . 0 0 4 ) ,   a d-
vanced age (p= 0.010), weight loss (p= 0.020), chronic 
diarrhea (p= 0.006), change of bowel habits (p= 0.043), 
epigastric tenderness (p= 0.037), raised CEA level (p= 
0.039), < 10 gr/dl Hb level (p=0.054). None of these 
r i s k   f a c t o r s   h a d   b e e n   p r e s e n t   i n   2 1   ( 2 3 % )   w o m e n  
y o u n g e r   t h a n   5 1   y e a r s .   I n   t h i s   g r o u p ,   n o   p a t i e n t   h a d  
any GI lesion likely to cause IDA (negative predictive 
value= 100%). In multivariate analysis, advanced age 
(p=0.017),  male  gender  (p<  0.01)  and  weight  lost 
( p = 0 . 0 1 2 )   f o u n d   t h a t   a s s o c i a t e d   w i t h   G I   l e s i o n s   i n   a l l  
patients. 
In addition, we determine the yield of endosco-
p y   e v a l u a t i o n s   i n   p r e -menopausal  and  age  <  50 
women with iron deficiency anemia but without any 
clinically  significant  sign-symptoms  and  laboratory 
findings. T h e r e   w e r e   2 1   p a t i e n t s   h a d   t h e s e   c r i t e r i a   b u t  
none of them had any endoscopic significant lesions. 
 
Table 7. Pathological conditions of the GI tract associated 
with iron deficiency (Clinically meaningful lesions) 
  Patients number 
Celiac disease (villous atrophy)   3 
Erosive gastritis  1 
Peptic ulcer  3 
IID*/chronic colitis  4 
Diverticulitis  3 
Gastric cancer  1 
Colon cancer  1 
Familial polyposis  1 
Helicobacter pylori gastritis  18 
*Inflammatory intestinal disease (Not: Hemorrhoid did not consi-
derate due to coincidentally lesions.  
 
Table 8. Rate of clinically significant lesions in IDA with 
positively symptoms-sign or laboratory results 
Symptoms, sign or labor-
atory 
results 
Existence of 
significant 
lesion  
Absence of 
significant 
lesion  
 P value 
Age> 50  8  12  0.010 
Sex (Male)  7  7  0.004 
Diarrhea  3  0  0.006 
Lost weight  3  1  0.020 
Change of bowel habits   3  2  0.043 
Epigastric tenderness   4  4  0.037 
Serological of sprue   2  1  0.074 
Hb level  7  50  0.054 
High CEA level  3  2  0.039 
Melena  2  2  0.157 
Constipation  10  29  0.178 
Cancer in first degree 
relatives  
7  15  0.112 
Fecal occult blood test 
positiviy 
5  11  0.178 
High CRP level  3  6  0.173 
High ESR level  6  13  0.174 
Whatever positively in 
general evaluation 
17  53  0.010 
 
Discussion 
I r o n   d e f i c i e n c y   i s   t h e   m o s t   c o m m o n   h e m a t o l o g-
ical  disorder  encountered  in  general  practice  and 
iron-deficiency anemia is the most frequently cause of 
a n e m i a   w o r l d w i d e   [ 1 3 ] .   B l o o d   l o s s   i s   a   m a j o r   c a u s e   o f  Int. J. Med. Sci. 2011, 8 
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iron-deficiency anemia [14]. However, the commonest 
c a u s e   o f   I D A   i n   d e v e l o p i n g   c o u n t r i e s   i s   s t i l l   n u t r i-
tional  deficiency.  In  some  instances,  an  insufficient 
s u p p l y   o f   i r o n   m a y   c o n t r i b u t e   t o   t h e   d e v e l o p m e n t   o f  
iron deficiency. The consumption of an iron-deficient 
d i e t ,   s u c h   a s   o c c u r s   i n   s t r i c t   v e g a n s ,   c a n   d e p l e t e   i r o n  
s t o r e s   i f   t h e   d i e t   i s   a d h e r e d   t o   f o r   t h r e e   o r   m o r e   y e a r s  
in the absence of excessive losses [15].  
Iron-deficiency anemia is not a disease itself but 
a   m a n i f e s t a t i o n   o f   a n   u n d e r l y i n g   d i s e a s e ,   s earching 
for the latter is therefore crucial and may be of far 
greater importance to the ultimate well-being  of  the 
patient than repleting iron stores. This is particularly 
important, because a large proportion of patients with 
IDA does not undergo endoscopy or are incompletely 
evaluated,  despite  specific  guidelines  [16-17].  These 
procedures  are  not  cost-e f f e c t i v e   f o r   e a c h   I D A   p a-
t i e n t s .   I n   f a c t   d u e   t o   e c o n o m i c   o r   p r a c t i c a l   c o n s i d e r a-
tion,  not  all iron deficiency  patients  could  be  fully 
investigated. And, in 2 0 %   o f   p a t i e n t s   w i t h   I D A   a   r o u-
tine upper and lower GI endoscopy may not ascertain 
G I   c a u s e   d u r i n g   h o s p i t a l   a d m i s s i o n   [ 1 8 ] .   C a n c e r   w a s  
diagnosed  in  13.1%  and  gastrointestinal  cancer  in 
1 1 . 2 %   o f   p a t i e n t s   w i t h   I D A .   B u t   t w o   s t u d i e s   r e p o r t e d  
t h a t   I D A   w a s   o n e   o f  the predictive factors of colorectal 
cancer and small intestinal cancer [19-20].  The  stan-
d a r d   p r o c e d u r e   f o r   i n v e s t i g a t i n g   t h e   s o u r c e   o f   I D A  
a m o n g   m e n   a n d   p o s t m e n o p a u s a l   w o m e n   i s   t o   r u l e  
out gastrointestinal tract pathology and a nutritional 
cause [17-18, 21-2 3 ] .   I n   p r e -menopausal women, iron 
deficiency anemia is common and menstrual flow is 
o f t e n   h e l d   r e s p o n s i b l e ,   b u t   i t   i s   n o t   c l e a r   w h e t h e r  
these women should be submitted to gastrointestinal 
(GI) evaluation. 
I r o n   d e f i c i e n c y   a n e m i a   r e s u l t s   f r o m   c h r o n i c   o c-
cult gastrointestinal bleeding. Endoscopic evaluation 
of the gastrointestinal tract is commonly performed to 
evaluate  iron  deficiency.  Most  of  patients  with  iron 
deficiency in, whom gastrointestinal or systemic signs 
or  symptoms  are  absent  have  an  underlying  ga-
strointestinal  lesion  [24].  Idiopathic  iron-deficiency 
anemia  in  adults  is  widely  believed to  result  from 
chronic  colonic  blood  loss  due  to  mass  lesions.  A 
thorough  examination  of  the  gastrointestinal  tract, 
particularly the colon, has become standard practice, 
previously [25-26].  
T h e   m o s t   o f   s t u d i e s   s h o w n   t h a t   s u b s t a n t i a l   g a-
strointestinal lesions, particularly those  of  the  upper 
gastrointestinal  tract,  are  common  in  patients  with 
iron deficiency anemia. Cook et al. [4] shown that 40% 
o f   p a t i e n t s   h a d   u p p e r   G I   t r a c t   l e s i o n s   a n d   Kepczyk et 
a l .   [ 3 ]   s h o w e d   t h a t   5 5 %   o f   p a t i e n t s   h a d   u p p e r   G I   t r a c t  
lesions. In generally, 41% of patients had upper GI 
tract lesions [7]. In our study, 52 of 91 patients (57%) 
had  upper  GI  tract  conditions.  The  most  common 
abnormality  in  the  upper  gastrointestinal  tract  was 
esophagitis,  gastritis  or  duodenitis,  gastric  ulcer  or 
duodenal ulcer and gastric cancer, in these studies. In 
our  study,  most  common  abnormality  in  upper  ga-
strointestinal  tract  was antral  gastritis, H.  pylori  ga-
stritis, duodenitis and pangastritis. Two patients had 
gastric ulcer, 2 had duodenal ulcer and 1 patient had 
gastric cancer. The rate of lower gastrointestinal tract 
abnormality in iron deficiency anemia patients was 
13.5-30% in literature [7] a n d   3 0 %   i n   o u r   s t u d y .   C a n c e r  
w a s   t h e   m o s t   c o m m o n   l e s i o n   i n   t h e   c o l o n .   H o w e v e r ,  
o n l y   o n e   p a t i e n t   h a d   c o l o n   c a n c e r   i n   o u r   s t u d y .   B e-
cause of postmenopausal women and men patients’ 
number were higher in literature than our study. For 
example,  Rockey  et  al.  study  had  9/100 
pre-menopausal  women  but  our  study  had  66/91 
pre-menopausal women patients. 
M a n y   o f   t h e   c a u s e s   i d e n t i f i e d   i n   o u r   s t u d y ,   p a r-
t i c u l a r l y   i n   t h e   u p p e r   G I   t r a c t   h a v e   s i m i l a r   t r e a t m e n t .  
Further,  we  identified  1  gastric  and  1  colon  cancer 
p a t i e n t   i n   o u r   s t u d y .   A n  early gastric cancer was di-
a g n o s e d   o n   b i o p s y   o f   a   s u s p i c i o u s   u l c e r a t e d   a r e a   i n   a  
45-year-old  man  patient.  Partial  gastrectomy  was 
successful and remains well. An 82-year-old man was 
diagnosed adenocarcinoma by endoscopic biopsy. A 
right hemicolectomy was performed, and the patient 
had no any metastasis. Three years after surgery, he is 
alive without any symptoms.  
The standard diagnostic procedure for men and 
postmenopausal  women  with  iron  deficiency  is  to 
investigate  gastrointestinal  tract  (upper  and  lower) 
pathology  as  well  as  rule  out  a  nutritional  cause 
[27-2 8 ] .   T h e   d i a g n o s t i c   v a l u e   o f   e n d o s c o p y   w a s   5 8 %   i n  
these conditions [3, 29-32]. Endoscopy demonstrated a 
lesion in 7 of the 11 pre-menopausal women patients 
a n d   1 2   o f   t h e   1 4   m e n   p a t i e n t s ;   s i g n i f i c a n t   risk factors 
for gastrointestinal lesions in these patients were old-
e r   a g e   a n d   m a l e   s e x   ( p   v a l u e ;   0 . 0 1 0 –0.004, respective-
ly).  The  prevalence  of  gastrointestinal  malignancy 
was  6-23% in these group patients [24, 28-29, 3] but 
o n l y   t w o   m e n   p a t i e n t s   ( 2   o f   t h e  14 patients) had ga-
strointestinal malignancy.  
The ability to predict the site of GI lesions that 
c a u s e   I D A   c o u l d   o p t i m i z e   t h e   e n d o s c o p i c   a p p r o a c h .  
B u t ,   t h e   p r e v i o u s   s t u d i e s   h a v e   f o u n d   t h a t   s y m p t o m s  
and signs are poor indicators of the site of lesions 
causing  IDA  and,  thus,  are  not  helpful  in  choosing 
appropriate investigative tests [34-35]. Capurso et al. 
suggested  that  accurate  initial  assessment  of  patient 
characteristics, clinical history, and certain laboratory 
d a t a   m a y   g u i d e   t h e   c h o i c e   o f   w h i c h   e n d o s copic in-
vestigation to perform first in patients with IDA, the-
reby, potentially reducing the frequency of negative Int. J. Med. Sci. 2011, 8 
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findings. By using multiple logistic regression analy-
sis, no statistically significant risk factor for the pres-
ence  of  upper-GI  tract  diseases   l i k e l y   t o   c a u s e   I D A  
was  identified.  None  of  the  variables  investigated 
were predictive of upper-G I   t r a c t   l e s i o n s   [ 3 6 ] .   In our 
study,  no  statistically  significant  association  for  the 
presence of dyspepsia score between organic lesions 
was  identified.  But,  the  only  statistically  significant 
r i s k   f a c t o r s   f o r   t h e   p r e s e n c e   o f   G I   t r a c t   d i s e a s e   l i k e l y  
t o   c a u s e   I D A   w e r e   t h e   f o l l o w i n g ;   d i a r r h e a ,   weight 
loss, change of bowel habits and epigastric tenderness 
in our study. The statistically limited association for 
t h e   p r e s e n c e   o f   G I   t r a c t   l e s i o n s   w e r e   f o l l o w i n g ;   c o n-
stipation, melena and a   f a m i l y   h i s t o r y   o f   a   f i r s t -degree 
relative with GI cancer.  
Capurso  et  al.  demonstrated  that  a  positive 
FOBT and older age were  associated  with  the  pres-
e n c e   o f   G I   t r a c t   o r g a n i c   l e s i o n s   [ 3 6 ] .   In  our  study, 
p r e d i c t i v e   r i s k   f a c t o r s   f o r   G I   t r a c t   l e s i o n s   t o   c a u s e   o f  
IDA were older age (>50 years) and positive FOBT. 
C a p u r s o   e t   a l .   s h o w e d   t h a t   t h e   r i s k   f a c t o r s   f o r   G I   m a-
lignancies were: male gender (p < 0.01), advanced age 
( p   <   0 . 0 1 ) ,   a n d   l o w e r   m e a n   c o r p u s c u l a r   v o l u m e   ( p < 
0.002).  
The standard diagnostic procedure for men and 
postmenopausal  women  with  iron  deficiency  is  to 
investigate  gastrointestinal  tract  (upper  and  lower) 
pathology. T h e   c a u s e   o f   i r o n   d e f i c i e n c y   a n e m i a   ( I D A )  
in  pre-m e n o p a u s a l   w o m e n   i s   o f t e n   p r e s u m e d   t o   b e  
m e n s t r u a l   b l o o d   l o s s .   T h e r e   a r e   s p a r s e   d a t a   o n   g a-
strointestinal  investigations  in  pre-menopausal 
women who have IDA, but significant gastrointestinal 
pathology  was  detected  in  published  studies  [29, 
37-39].  Significant  upper  gastrointestinal  disease  is 
identifiable  among  most  pre-menopausal  women 
w i t h   I D A   ( 1 8   o f   1 9   o r   9 5 % ) ,   e v e n   w h e n   c a r e f u l   e v a l u-
ation by a specialist in gynecology suggests a gyne-
cological  source  [38] .   U p p e r   e n d o s c o p y   s h o u l d   b e  
considered in the evaluation of all pre-menopausal 
women with IDA expressing digestive complaints or 
in those with IDA refractory to iron supplementation. 
Lower endoscopic examination may be reserved for 
those women with symptoms or signs suggestive of 
colorectal disorders [38]. Nahon et al. aimed to eva-
luate  the  diagnostic  yield  of  endoscopy  in  women 
w i t h   I D A   a n d   t o   d e f i n e   p r e d i c t i v e   f a c t o r s   o f   a   G I   l e-
sion.  241  consecutive  women  had  endoscopies  for 
I D A .   P r e d i c t i v e   f a c t o r s   o f   G I   lesions  diagnosed  by 
e n d o s c o p y   w e r e   a b d o m i n a l   s y m p t o m s ,   a g e   >   5 0  
y e a r s ,   a n d   H b   <   9   g / d l .   T h e y   s u g g e s t e d   t h a t   e n d o s-
copic  investigation  should  be  avoided  in  women 
without  these  three  predictive  factors  [39].  In  our 
study, none of these risk factors had been present in 
21 (23%) women younger than 51 years. In this group, 
n o   p a t i e n t   h a d   a n y   G I   l e s i o n   l i k e l y   t o   c a u s e   I D A  
(negative  predictive  value=  100%).  Pre-menopausal 
w o m e n   a n d   y o u n g   p a t i e n t s   w i t h   I D A   m a y   a l s o   p r o-
vide unique diagnostic challenges. The accurate initial 
assessment of patient characteristics, clinical history, 
a n d   c e r t a i n   l a b o r a t o r y   d a t a   m a y   g u i d e   t h e   c h o i c e   o f  
which  endoscopic  investigation  to  perform  first  in 
patients  with  IDA  (especially  in  pre-menopausal 
women), thereby, potentially reducing the frequency 
of negative findings. It may be an appropriate clinical 
approach to consider these risk factors when deciding 
for gastrointestinal endoscopic evaluation in iron de-
ficiency anemia.  
Helicobacter pylori infection has been implicated 
in several r e c e n t   s t u d i e s   a s   a   c a u s e   o f   I D A   r e f r a c t o r y  
t o   o r a l   i r o n   t r e a t m e n t   w i t h   a   f a v o r a b l e   r e s p o n s e   t o   H. 
pylori eradication [40-46]. In our study, 18 of 91 IDA 
patients  (19.8%)  had  Helicobacter  pylori  gastritis. 
Hershko et al. showed that H. pylori infection was the 
o n l y   f i n d i n g   i n   2 9   o f   1 5 0   p a t i e n t s   ( 1 9 % ) ,   b u t   w a s   a  
common co-existing finding in 77 (51%) of the entire 
g r o u p   [ 4 7 ] .   T h e   c e l i a c   d i s e a s e   a s   a   p o s s i b l e   c a u s e   o f  
IDA  refractory  to  oral iron  treatment, without  other 
apparent  manifestations  of  malabsorption syndrome 
is  increasingly  being  recognized.  Celiac  disease 
s h o u l d   b e   i n c l u d e d   a n d   r o u t i n e l y   l o o k e d   f o r   i n   t h e  
differential  diagnosis  of  adult  patients  with  IDA. 
Grisolano et al. showed that the celiac disease preva-
lence was 8.7% in IDA patients [48]. Three patients 
had celiac disease in our study.  
I n   c o n c l u s i o n ,   o u r   s t u d y   d e m o n s t r a t e d   t h a t   i t 
m a y   b e   a n   a p p r o p r i a t e   c l i n i c a l   a p p r o a c h   t o   c o n s i d e r  
these  risk  factors  when  deciding  for  gastrointestinal 
endoscopic evaluation in iron deficiency anemia. But, 
the sample size o f   t h i s   s t u d y   w a s   t o o   s m a l l   t o   d r a w  
any reasonable conclusions. 
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